Excited to attend NVIDIA GTC next week in San Jose! ReSync Bio will be around during the week - stay tuned for updates on how we're working with NVIDIA Healthcare to democratize access to top AI tools for drug discovery. If you're looking to integrate AI into your DMTA workflow, book a demo: - https://lnkd.in/gaAkf9e4 (GTC In-Person) - https://lnkd.in/gG-7P3MP (Virtual) And if you're building the best models in preclinical drug discovery, reach out to us at [email protected] to learn how we can boost distribution of your tools. Shoutout to Stacie Calad-Thomson Janet Paulsen, PhD Roy Tal Kushal Shah Kenneth Gong and their teams for being excellent collaborators the past few months!
关于我们
ReSync coordinates labs, data, and AI models on one platform. Stop wrangling with emails and spreadsheets – find data and make decisions twice as fast.
- 网站
-
https://resync.bio
ReSync Bio的外部链接
- 所属行业
- 软件开发
- 规模
- 2-10 人
- 总部
- San Francisco，California
- 类型
- 私人持股
地点
-
主要
获取路线
US，California，San Francisco
ReSync Bio员工
动态
-
ReSync Bio转发了
Thank you Stacie Calad-Thomson for hosting the ReSync Bio team at NVIDIA HQ last week! We're excited to make AI in Drug Discovery more accessible by building BioNeMo and NIMs into the ReSync platform. Stay tuned for more content on how to run DiffDock, MolMIM, GenMol, and more on ReSync - no code needed! Reach out to learn more: https://lnkd.in/gku89aT4
-
-
How do we address Eroom's law (https://lnkd.in/gyqMXr4M.) in drug discovery? Read ReSync Bio's take on addressing the grand challenge here: https://lnkd.in/gBB5Z8Jt
-
-
We’re excited to announce the launch of ReSync Bio, a step change for drug discovery. ReSync is building the modern platform for integrated preclinical R&D. In order to properly leverage advancements in AI for drug discovery, teams need better tools to manage their data, ML models, and experimental workflows. With ReSync, teams of all sizes - from academic groups and startups to biotechs and pharma - can focus on the most important part of their jobs: scientific advancement. ReSync’s mission is to exponentially accelerate the speed of preclinical discovery: bringing cures to patients as quickly as possible. Learn more: https://www.resync.bio/